Iomeprol
Ioversol (INN) stands as a paramount member of the organoiodine compound class, functioning primarily as a contrast medium. Its chemical makeup, punctuated by a high iodine content and bolstered by multiple hydrophilic groups, grants it a unique efficacy and versatility in medical imaging.
Chemical Composition and Characteristics
Central to Ioversol's effectiveness as a contrast medium is its high iodine content. Iodine, with its significant atomic number, is adept at attenuating X-rays, thus allowing for enhanced visualization during radiological studies. Complementing this property, the inclusion of several hydrophilic groups in its molecular structure augments its solubility in aqueous solutions, ensuring optimal delivery and distribution within the body[1].
Medical Applications and Utility
Ioversol is predominantly employed in the following diagnostic procedures:
- Computed Tomography (CT) - Here, Ioversol provides enhanced differentiation between tissues, particularly vital in cranial, thoracic, and abdominal imaging.
- Angiography - When evaluating blood vessels for potential blockages or anomalies.
- Urography - Ioversol aids in delineating the urinary tract, providing clarity on potential pathologies or obstructions.
- Its hydrophilic nature contributes to its even distribution and rapid elimination, mitigating the risk of pooling or excessive retention[2].
Safety Profile and Considerations
While Ioversol is generally well-tolerated, clinicians must remain vigilant of potential adverse reactions:
- Allergic reactions, ranging from mild skin rashes to severe anaphylactic shock.
- Contrast-induced nephropathy, particularly in patients with pre-existing renal compromise.
- Mild gastrointestinal disturbances, such as nausea.
- A thorough patient assessment, prioritizing renal function and allergy history, is essential before the administration of Ioversol[3].
Conclusion
- Ioversol, with its unique combination of iodine content and hydrophilic characteristics, stands out as an indispensable tool in modern radiology. By aiding clinicians in producing clearer and more detailed images, it has significantly advanced the field of diagnostic medicine. However, the safe and effective administration requires an understanding of its pharmacokinetics and potential adverse reactions.
References
- Thomsen, H. S., Morcos, S. K., & Dawson, P. (2004). Is there a causal relation between the administration of the iodinated contrast media and the development of nephropathy?. Clinical Radiology, 59(9), 753-759.
- Barrett, B. J., & Katzberg, R. W. (1997). Risk of iodinated contrast material-induced nephropathy with intravenous administration. Radiology, 203(1), 37-41.
- McDonald, J. S., McDonald, R. J., Carter, R. E., Katzberg, R. W., Kallmes, D. F., & Williamson, E. E. (2014). Risk of intravenous contrast material-mediated acute kidney injury: a propensity score-matched study stratified by baseline-estimated glomerular filtration rate. Radiology, 271(1), 65-73.
| Contrast media (V08) | ||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
- ↑ Thomsen, H. S., Morcos, S. K., & Dawson, P. (2004). Is there a causal relation between the administration of the iodinated contrast media and the development of nephropathy?. Clinical Radiology, 59(9), 753-759.
- ↑ Barrett, B. J., & Katzberg, R. W. (1997). Risk of iodinated contrast material-induced nephropathy with intravenous administration. Radiology, 203(1), 37-41.
- ↑ McDonald, J. S., McDonald, R. J., Carter, R. E., Katzberg, R. W., Kallmes, D. F., & Williamson, E. E. (2014). Risk of intravenous contrast material-mediated acute kidney injury: a propensity score-matched study stratified by baseline-estimated glomerular filtration rate. Radiology, 271(1), 65-73.
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
